Your browser is no longer supported. Please, upgrade your browser.
Settings
AGN Allergan plc daily Stock Chart
AGN [NYSE]
Allergan plc
IndexS&P 500 P/E- EPS (ttm)-11.66 Insider Own0.20% Shs Outstand335.20M Perf Week-7.10%
Market Cap68.60B Forward P/E11.54 EPS next Y17.73 Insider Trans-0.27% Shs Float333.57M Perf Month-7.93%
Income-3981.80M PEG- EPS next Q4.13 Inst Own86.50% Short Float1.87% Perf Quarter-16.96%
Sales15.07B P/S4.55 EPS this Y63.30% Inst Trans-2.01% Short Ratio2.88 Perf Half Y-13.77%
Book/sh209.70 P/B0.98 EPS next Y9.33% ROA8.90% Target Price270.78 Perf Year-15.93%
Cash/sh17.38 P/C11.77 EPS next 5Y12.95% ROE15.70% 52W Range184.50 - 256.80 Perf YTD-2.55%
Dividend2.80 P/FCF269.33 EPS past 5Y-28.70% ROI0.10% 52W High-20.31% Beta1.17
Dividend %1.37% Quick Ratio1.10 Sales past 5Y26.00% Gross Margin87.10% 52W Low10.92% ATR5.41
Employees16700 Current Ratio1.20 Sales Q/Q8.80% Oper. Margin-20.80% RSI (14)24.64 Volatility3.36% 2.38%
OptionableYes Debt/Eq0.43 EPS Q/Q-88.00% Profit Margin77.30% Rel Volume1.81 Prev Close202.66
ShortableYes LT Debt/Eq0.38 EarningsNov 02 BMO Payout5.00% Avg Volume2.17M Price204.65
Recom2.10 SMA20-8.36% SMA50-12.61% SMA200-11.34% Volume3,903,828 Change0.98%
Sep-20-17Downgrade Morgan Stanley Overweight → Equal-Weight
Jun-16-17Initiated Cantor Fitzgerald Neutral $231
Jun-09-17Reiterated Mizuho Buy $275 → $267
May-10-17Reiterated RBC Capital Mkts Outperform $279 → $284
May-10-17Downgrade Goldman Buy → Neutral
Feb-09-17Reiterated Mizuho Buy $273 → $275
Dec-09-16Reiterated Credit Suisse Outperform $301 → $274
Nov-17-16Reiterated Mizuho Buy $293 → $273
Nov-03-16Reiterated RBC Capital Mkts Outperform $300 → $279
Nov-01-16Reiterated Mizuho Buy $299 → $293
Oct-31-16Resumed Barclays Equal Weight $250
Oct-11-16Reiterated Mizuho Buy $305 → $299
Aug-19-16Upgrade Mizuho Neutral → Buy $248 → $318
Aug-09-16Reiterated RBC Capital Mkts Outperform $307 → $300
Aug-09-16Reiterated Deutsche Bank Buy $282 → $278
Aug-05-16Reiterated Mizuho Neutral $232 → $246
Jul-27-16Reiterated Leerink Partners Outperform $272 → $294
Jul-25-16Initiated Credit Suisse Outperform $327
May-13-16Reiterated Mizuho Neutral $250 → $232
Apr-18-16Resumed Goldman Buy $275
Sep-22-17 04:49PM  Allergan Receives Refusal to File Letter from FDA for Vraylar® (cariprazine) Supplemental New Drug Application (sNDA) for the Treatment of Negative Symptoms in Schizophrenia PR Newswire
04:38PM  Why Allergan's Hepatitis Drug Likely Won't Get FDA Approval Investor's Business Daily
03:04PM  Native American tribe moves to dismiss Allergan patent case Reuters
02:30PM  Native American tribe moves to dismiss Allergan patent case Reuters
12:01PM  Allergan Needs to Learn to Let Go Bloomberg
08:00AM  New Data from CENTAUR Phase 2b Clinical Study Supports Continued Development of Cenicriviroc (CVC) in Ongoing Phase 3 AURORA Trial PR Newswire
Sep-21-17 11:09AM  How Does Allergan plc (AGN) Affect Your Portfolio Returns? Simply Wall St.
10:15AM  How is the Age-Related Macular Degeneration Space Faring Now? Zacks
Sep-20-17 12:33PM  Allergan: Just How Far Will Big Pharma Go To Protect Its Patents? Barrons.com
08:04AM  See what the IHS Markit Score report has to say about Allergan plc. Markit
04:00AM  Apple Likes the Patent Death Squad. Allergan Pays to Avoid It Bloomberg
12:24AM  [$$] States Push Ahead With Investigation Into Opioid Painkillers The Wall Street Journal
Sep-19-17 06:05PM  [$$] States Push Ahead With Investigation Into Opioid Painkillers The Wall Street Journal
02:55PM  States expand investigation of opioid makers, distributors Associated Press
12:22PM  State attorneys general subpoena opioid makers and dealer... CNBC Videos
11:58AM  The only thing Trump is doing to end the opioid crisis rewards the companies that started it Business Insider
09:35AM  Should Value Investors Consider Allergan plc (AGN) Stock Now? Zacks
07:35AM  Allergan Innovation Recognized With Three 2017 Allure Best of Beauty Breakthrough Awards PR Newswire
Sep-18-17 01:58PM  AMD leading IQ100 top gainers CNBC Videos
12:37PM  Why Allergan Could Be A $300 Stock Barrons.com
Sep-16-17 07:27AM  Allergan's Restasis Patent Transfer to Face Precedent-Setting Legal Battle TheStreet.com
Sep-15-17 01:56PM  U.S. senator slams Allergan patent deal with Native-American tribe Reuters
11:42AM  U.S. senator slams Allergan tribal patent deal Reuters
10:33AM  Amgen/Allergan's Avastin Biosimilar Secures FDA Approval Zacks
06:00AM  3 Dividend Healthcare Stocks Motley Fool
Sep-14-17 09:30PM  A Biosimilar Cure for Sky-High Cancer Drug Prices Motley Fool
05:23PM  Challenge of Allergan tribal patent deal in uncharted legal territory Reuters
03:28PM  Apple, JPMorgan Among Top Picks On New List From UBS Benzinga
03:12PM  Amgen and Allergan say FDA has approved biosimilar of Roche's Avastin MarketWatch
02:56PM  Allergan plc Ordinary Shares (AGN) May Have Just Saved Itself Billions InvestorPlace
02:54PM  FDA Approves Amgen And Allergan's MVASI (bevacizumab-awwb) For The Treatment Of Five Types Of Cancer PR Newswire
11:22AM  These party drugs could become the answer for clinically ... CNBC Videos
11:12AM  AstraZeneca Sells Remaining Rights to its Anaesthetics Drugs Zacks
08:02AM  See what the IHS Markit Score report has to say about Allergan plc. Markit
Sep-13-17 05:59PM  "Fast Money" final trades: TGT, TMO and more CNBC Videos
04:41PM  Why pharma companies are scared of Bernies Medicare for All plan Quartz
08:03AM  See what the IHS Markit Score report has to say about Allergan plc. Markit
07:43AM  Early movers: DIS, JWN, AAL, AGN, CNC, TEX, MU, MNK & more CNBC
Sep-12-17 06:16PM  Tech entity has tribal patent deal similar to Allergan's Reuters
05:15PM  Mylan says Allergan misusing tribal sovereignty in patent dispute Reuters
04:05PM  Allergan Launches New Brilliant Distinctions® Patient Loyalty Program PR Newswire
08:02AM  See what the IHS Markit Score report has to say about Allergan plc. Markit
Sep-11-17 10:12PM  U.S. tribal patent deal could have big impact on generic drug market Reuters
07:56PM  Irma to Bring Droves to Aisles of Home Depot; Teva Reveals Savior CEO - ICYMI TheStreet.com
07:27PM  Cramer's lightning round: Allergan's in a torturous situa... CNBC Videos
07:22PM  U.S. tribal patent deal could have big impact on generic drug market Reuters
06:51PM  Cramer's lightning round: Allergan's in a torturous situation CNBC
06:22PM  U.S. tribal patent deal could have big impact on generic drug market Reuters
11:59AM  Why Did Teva Pharmaceuticals Stock Soar Today? Zacks
11:00AM  Here's Why Allergan Stock Might Be an Incredible Bargain After Dropping 9.9% in August Motley Fool
10:07AM  See what the IHS Markit Score report has to say about Allergan plc. Markit
09:26AM  Sovereign Immunity and Public Hangings Bloomberg
09:21AM  The Allergan Foundation to Donate $150,000 to Support Hurricane Irma Relief Efforts PR Newswire
07:25AM  Allergan Patent Deal Isn't Just Unusual. It's Ugly. Bloomberg
07:17AM  Allergan's Patent Loophole Could Be a Huge Gift for Pfizer Motley Fool
Sep-10-17 08:33AM  3 Reasons to Buy Allergan plc Stock Right Now Motley Fool
01:00AM  The Media Is the Message; Allergan Gets Jiggy: Doug Kass' Views TheStreet.com
Sep-09-17 03:00AM  Amgen And Allergan Present Phase 3 Data On Biosimilar Trastuzumab Candidate ABP 980 At The European Society For Medical Oncology 2017 Congress PR Newswire
12:01AM  Casinos Aren't Enough as Native Tribe Makes Deal on Drug Patents Bloomberg
12:01AM  Casinos Arent Enough as Native Tribe Makes Deal on Drug Patents Bloomberg
Sep-08-17 11:43PM  [$$] Allergan Partners With Indian Tribe to Protect Drug Patents The Wall Street Journal
05:14PM  Allergan Shares Rise on Novel Patent Pact for Restasis TheStreet.com
04:29PM  [$$] Allergan Partners With Indian Tribe to Protect Drug Patents The Wall Street Journal
03:32PM  Allergan pays Mohawk Tribe to protect patents from challenges Reuters
03:29PM  Forget casinos: This Native American tribe is doing business in pharma patents CNBC
03:09PM  Allergan has made an unorthodox agreement with an American Indian tribe to fend off competition for its key product MarketWatch
02:45PM  Allergan pays Mohawk Tribe to protect patents from challenges Reuters
02:13PM  Forget casinos: This Native American tribe is doing business in pharma patents CNBC
02:08PM  Allergan $13.75 mln agreement with Saint Regis Mohawk Tribe a play to protect key dry eye product MarketWatch
01:43PM  Allergan reaches agreement regarding RESTASIS patents CNBC Videos
12:53PM  A Native American Tribe, a Drugmaker and an Unusual Patent Plan Bloomberg
12:34PM  Allergan and Saint Regis Mohawk Tribe Announce Agreements Regarding RESTASIS® Patents PR Newswire
11:07AM  [$$] Merck Tops JNJ, Allergan Barrons.com
08:01AM  Pro Football Hall of Famer Deion Sanders Tackles Frown Lines And Crow's Feet With BOTOX® Cosmetic (onabotulinumtoxinA)1 PR Newswire
Sep-07-17 09:41AM  Aerie Initiates Phase III Study for Ophthalmic Drug Roclatan Zacks
08:45AM  Allergan Plc :AGN-US: Earnings Analysis: Q2, 2017 By the Numbers : September 7, 2017 Capital Cube
07:20AM  Watertowns Lyndra strikes Alzheimers pact with Allergan worth up to $105M American City Business Journals
Sep-06-17 10:56AM  Is It The Right Time To Buy Allergan plc (AGN)? Simply Wall St.
07:35AM  Allergan to Present New Data on Chronic Migraine at the International Headache Congress in Vancouver PR Newswire
Sep-05-17 04:51PM  Why Mallinckrodt Got Crushed Barrons.com
Sep-04-17 08:45AM  Allergan (AGN) Down 8.3% Since Earnings Report: Can It Rebound? Zacks
Sep-01-17 07:09PM  Cramer's biggest investing mistakes CNBC Videos
06:44PM  Cramer admits his biggest investing mistakes CNBC
07:57AM  Pharma Stock Roundup: Novartis CAR-T Drug Gets FDA Nod, Lilly Gives Baricitinib Update Zacks
Aug-30-17 10:01AM  Gilead-Kite: A New Transformative Deal For Biotech Forbes
Aug-29-17 10:23AM  Battered Teva Pharmaceutical Industries Ltd (ADR) Stock Still Is Toxic InvestorPlace
Aug-28-17 10:50PM  ALLERGAN 24 HOUR DEADLINE ALERT: Approximately 24 Hours Remain; ClaimsFiler Reminds Investors of Deadline in Class Action Lawsuit Against Allergan, Inc. - (AGN) Business Wire
04:15PM  Allergan Announces Settlement of RESTASIS® (Cyclosporine Ophthalmic Emulsion) 0.05% Patent Litigation with Famy Care PR Newswire
08:00AM  The Allergan Foundation to Donate $100,000 to Support Hurricane Harvey Relief Efforts PR Newswire
Aug-25-17 10:50PM  ALLERGAN 96 HOUR DEADLINE ALERT: Approximately 96 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action Lawsuit against Allergan, Inc. - (AGN) Business Wire
08:00AM  Allergan to Present at the 2017 Morgan Stanley Global Healthcare Conference PR Newswire
Aug-24-17 10:03PM  3 Top Healthcare Stocks to Buy Now Motley Fool
Aug-23-17 09:07AM  Key Developments for Allergan in 2Q17 Market Realist
08:31AM  The Zacks Analyst Blog Highlights: Allergan, Ecolab, Exelon, GlaxoSmithKline and Rockwell Collins Zacks
08:30AM  Allergan Teams Up With Comedian Vanessa Bayer and OB/GYN Jessica Shepherd, M.D., M.B.A, to Debut the Know Your Birth Control Campaign PR Newswire
07:37AM  How Allergans International Segment Performed in 2Q17 Market Realist
Aug-22-17 10:50PM  ALLERGAN SHAREHOLDER ALERT: CLAIMSFILER Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Allergan, Inc. - (AGN) GlobeNewswire
05:15PM  Top Analyst Reports for Allergan, Ecolab & Exelon Zacks
01:25PM  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Allergan, Inc. - AGN PR Newswire
10:36AM  How Did Allergans US General Medicines Segment Perform in 2Q17? Market Realist
Allergan plc, a specialty pharmaceutical company, develops, manufactures, markets, and distributes medical aesthetics, biosimilar, and over-the-counter pharmaceutical products worldwide. It operates through US Specialized Therapeutics, US General Medicine, and International segments. The company offers a portfolio of products that provide treatment for the central nervous system, gastroenterology, women's health and urology, ophthalmology, neurosciences, medical aesthetics, dermatology, plastic surgery, liver disease, inflammation, metabolic syndromes, and fibrosis, as well as Alzheimer's disease. It is also involved in developing ocular implants that reduce intraocular pressure associated with glaucoma; medical devices for the correction of prominent ears; and intranasal neurostimulation devices, as well as other dry eye products. In addition, the company distributes generic and branded pharmaceutical products primarily to independent and chain pharmacies, nursing homes, mail order pharmacies, hospitals, clinics, and physician offices. Further, it develops a portfolio of breast implants and tissue expanders; and RM-131 (relamorelin), a peptide ghrelin agonist for the treatment of diabetic gastroparesis. The company has licensing agreement with Assembly Biosciences, Inc.; Mimetogen Pharmaceuticals, Inc.; Almirall, S.A; Naurex, Inc.; and Merck & Co. The company was formerly known as Actavis plc and changed its name to Allergan plc in June 2015. Allergan plc was founded in 1983 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SAUNDERS BRENT LChairman, President and CEOJun 16Buy235.964410,327131,178Sep 18 08:49 PM
Basgoz NesliDirectorMay 18Option Exercise84.441,889159,5077,919May 22 04:26 PM
Basgoz NesliDirectorMay 18Sale220.451,889416,4306,030May 22 04:26 PM
GALLAGHER MICHAEL RDirectorMay 04Option Exercise245.2517,6934,339,20820,272May 05 06:34 PM
SAUNDERS BRENT LChairman, President and CEOMar 29Buy242.214310,299131,135Sep 18 08:49 PM
BISARO PAULDirectorMar 02Sale246.6870,00017,267,561235,900Mar 06 06:59 AM
Meury WilliamChief Commercial OfficerDec 08Option Exercise109.1211,8071,288,38048,866Feb 14 09:13 PM
Basgoz NesliDirectorDec 08Sale188.7250094,3605,515Dec 09 05:56 PM
SAUNDERS BRENT LCEO and PresidentNov 21Buy189.135,250992,941106,564Nov 21 04:03 PM
Hilado Maria TeresaChief Financial OfficerNov 11Buy210.641,422299,53613,379Nov 15 05:18 PM